Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis
- PMID: 18988226
- DOI: 10.1002/ijc.23943
Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis
Abstract
Epidemiological evidence indicates that the association between body weight and breast cancer risk may differ across menopausal status as well as the estrogen receptor (ER) and progesterone receptor (PR) tumor status. To date, no meta-analysis has been conducted to assess the association between body weight and ER/PR defined breast cancer risk, taking into account menopausal status and study design. We searched MEDLINE for relevant studies published from January 1, 1970 through December 31, 2007. Summarized risk estimates with 95% confidence intervals (CIs) were calculated using a random-effects model. The summarized results of 9 cohorts and 22 case-control studies comparing the highest versus the reference categories of relative body weight showed that the risk for ER+PR+ tumors was 20% lower (95% CI=-30% to -8%) among premenopausal (2,643 cases) and 82% higher (95% CI=55-114%) among postmenopausal (5,469 cases) women. The dose-response meta-analysis of ER+PR+ tumors showed that each 5-unit increase in body mass index (BMI, kg/m2) was associated with a 33% increased risk among postmenopausal women (95% CI=20-48%) and 10% decreased risk among premenopausal women (95% CI=-18% to -1%). No associations were observed for ER-PR- or ER+PR- tumors. For discordant tumors ER+PR- (pre) and ER-PR+ (pre/post) the number of cases were too small (<200) to interpret results. The relation between body weight and breast cancer risk is critically dependent on the tumor's ER/PR status and the woman's menopausal status. Body weight control is the effective strategy for preventing ER+PR+ tumors after menopause.
Copyright (c) 2008 Wiley-Liss, Inc.
Similar articles
-
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Breast Cancer Res Treat. 2010. PMID: 20711809 Review.
-
Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis of epidemiological studies.Int J Cancer. 2008 Apr 15;122(8):1832-41. doi: 10.1002/ijc.23184. Int J Cancer. 2008. PMID: 18067133
-
Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.Int J Cancer. 2006 Oct 1;119(7):1683-9. doi: 10.1002/ijc.22034. Int J Cancer. 2006. PMID: 16646051
-
Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.Int J Cancer. 2011 Sep 1;129(5):1214-24. doi: 10.1002/ijc.25744. Epub 2011 Apr 8. Int J Cancer. 2011. PMID: 21064092
-
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26. Ann Oncol. 2015. PMID: 26504151 Free PMC article. Review.
Cited by
-
Weight-centric prevention of cancer.Obes Pillars. 2024 Mar 5;10:100106. doi: 10.1016/j.obpill.2024.100106. eCollection 2024 Jun. Obes Pillars. 2024. PMID: 38495815 Free PMC article. Review.
-
The intersection of heart failure and cancer in women: a review.Front Cardiovasc Med. 2024 Feb 28;11:1276141. doi: 10.3389/fcvm.2024.1276141. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38481958 Free PMC article. Review.
-
The Effect of Melatonin Supplementation on Cancer-Related Fatigue during Chemotherapy Treatment of Breast Cancer Patients: A Double-Blind, Randomized Controlled Study.Cancers (Basel). 2024 Feb 16;16(4):802. doi: 10.3390/cancers16040802. Cancers (Basel). 2024. PMID: 38398193 Free PMC article.
-
Alterations in the mammary gland and tumor microenvironment of formerly obese mice.BMC Cancer. 2023 Dec 1;23(1):1183. doi: 10.1186/s12885-023-11688-3. BMC Cancer. 2023. PMID: 38041006 Free PMC article.
-
Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer.Breast Cancer Res. 2023 Oct 28;25(1):130. doi: 10.1186/s13058-023-01729-x. Breast Cancer Res. 2023. PMID: 37898792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials